Well said Mac and there will be no agreement on this thread as Traders and Investors are reading from two different pages IMO
Printable View
OK Snapiti, I agree that there is more to consider than the company's sales figures but I do believe that recorded Sales will be the driver for any sp momentum shift come end of May / early June. I've posted my strategy. Assuming you have one, would you care to share yours?
Moosie, there's no harm speculating if it helps to identify possible scenarios and firm up a strategy. Yes, speculation is assumption-laden but provided we research well enough to validate those assumptions, it can be very useful as a predictive tool.
Agreed Snapps - PEB is not yet a viable business. Sure it has much potential, but it also has much yet to prove. IMO, it remains speculative until such a time that sales (actual and forecast) are sufficient to produce a sustainable growth in earnings.
Pacific Edge have also told us, during the October 2013 capital raising, that it could take 12 months to close negotiations with those HMO’s, Kaiser Permanente, Intermountain and others, so we must allow them the time they told us it would take to do so.
Similarly, Pacific Edge have been keeping us up to date with Medicare discussions, Pacific Edge are already now a Medicare provider, and Chris Swan let us know in December that Obamacare requirements had to be worked through to finalise accreditation.
This is not unique to Pacific Edge the whole sector is working through the Obamacare processes, and all at the same time. Maybe, this occurred prior to 31 March, I suspect not, but even if so and either way any sales would not start to come through until the next reporting period.
“Mr Swann welcomed Obamacare as ''an opportunity'', but the legislative changes meant Pacific Edge had to wait longer and make changes to gain CMS accreditation, but he hopes it will be through early in 2014. 'Because Obamacare is orientated around health benefits, it wants to see value gains through [our] tests, he said.”
2014 will be a big year for Pacific Edge and IMO they will do well and prosper, and the HY15 report in November will be the opportunity for investors to assess progress, but not FY14 so much.
So many bytes of disc space and bandwidth on this chattering of sparrows and not one of you has spotted this or asked the important question:
Attachment 5810
Has Vince taken Hancocks Delete Button away?
Best Wishes
Paper Tiger
................ Quote Originally Posted by NewGuy
Agreed Turmeric.
To be honest, I don't think that the management and board are up to the task. They've said and done a number of things that (to me) seem quite naive. They seem to be out of their league, and appear to be struggling to make the transition from lab to boardroom. IMHO, this company will only really fly when they get more professional governance and management in place. And that isn't likely to happen until they get bought out. I hope it happens soon, though, as I'm currently nursing quite a bad paper loss on them right now!........................
Just because you are "nursing quite a bad paper loss on them right now!" doesn't mean the management and board are not up to the task. In fact there doesn't seem to be a lot of evidence to back up your view.
More likely either you bought at a frothy price or lack the patience for the company to prove itself?
Hey Mac
What value would you put on Peb shares when one of the large biotech come knocking on the door again. Which they will, Peb is now a prime target the most important thing a small bio company has is it's technology and pipeline.
A platform technology and a diversified, robust pipeline are always attractive to a potential acquirer. Large biotechs are looking for small biotechs that have strong pipelines [ Peb]. Having done the hard yards to get this far it might look to some a shame to be taken over, This is always a very exciting area for investors.
Geo ....$2.50 maybe ...better than $1.70
And petty cash to the big ones
And probably an inevitable outcome